Our findings suggest a particularly important role for SM22α in LXRα-mediated cholesterol homeostasis and contractile phenotype in VSMCs especially in the context of hypercholesterolemia and provide evidence that SM22α contributes to the anti-atherogenic effects of LXRα on VSMCs. Here, NR1H3 is linked to Hypercholesterolemia.